SulfonesPurinesCanadaPiperazinesPhosphodiesterase 5 InhibitorsPhosphodiesterase InhibitorsErectile Dysfunction3',5'-Cyclic-GMP PhosphodiesterasesCyclic Nucleotide Phosphodiesterases, Type 5Vasodilator AgentsPenile ErectionCyclic GMPHomosexuality, MaleMethamphetamineOntarioGeorgiaHypertension, PulmonaryBritish ColumbiaAlbertaQuebecCarbolinesImpotence, VasculogenicManitobaUnsafe SexPenisNova ScotiaRisk-TakingSexual BehaviorAdministration, OralNorthwest TerritoriesPhosphoric Diester HydrolasesPyrimidinonesTriazinesArctic RegionsSaskatchewanNunavutTreatment OutcomeInuitsPulmonary ArteryPriapismDouble-Blind MethodNewfoundland and LabradorCross-Over StudiesIndians, North AmericanTime FactorsAmerican Native Continental Ancestry GroupAntihypertensive AgentsQuestionnairesNitric OxideClitorisCyclic GMP-Dependent Protein KinasesDose-Response Relationship, DrugHypertrophy, Right VentricularPulmonary Wedge PressureVascular ResistanceDrug Therapy, CombinationDihydroergocristineSocieties, MedicalNew BrunswickIloprostBlood PressurePapaverineYukon TerritoryMedical TourismHemodynamicsRisk FactorsPrince Edward IslandEjaculationNational Health ProgramsHealth SurveysPrevalenceDrug CostsAlprostadil